Introduction {#Sec1}
============

Mutation of the fibrillin-1 gene (FBN1) leading to defective extracellular microfibrils results in divergence and instability of the entire connective tissue^[@CR1]^. In patients suffering from Marfan syndrome (MFS) the FBN1 mutation is inherited autosomal dominant with considerable phenotypical variability. The skeletal system, eyes, dura, skin and the pulmonary as well as the cardiovascular system are affected. Although MFS is a systemic disorder, reduced life expectancy is primarily determined by the extent of cardiovascular manifestations^[@CR2]^. Dilation of the aortic root is a result of increased aortic stiffness and pulse wave velocity, enhanced by fibrillin fragmentation due to the underlying FBN1 mutation^[@CR1]^.

The aortic valve-sparing reimplantation technique first described by David and Feindel^[@CR3]^ was originally developed as an aortic valve-sparing operation for patients with aortic valve incompetence and aneurysm of the ascending aorta^[@CR4]^. Today, prophylactic replacement of the dilated aortic root with preservation of the native aortic valve leads to excellent results, allowing an almost normal life-expectancy, avoiding the need of lifelong anticoagulation, especially for younger patients with MFS^[@CR5]--[@CR8]^.

Our study assesses outcome in patients with MFS operated on exclusively using the aortic valve-sparing reimplantation technique for aortic root aneurysms during more than a decade at a single center.

Patients and Methods {#Sec2}
====================

From March 2007 to December 2018, 229 patients underwent valve-sparing aortic root replacement (VSARR) at our department using the aortic valve-sparing reimplantation technique by David^[@CR3]^, of whom 56 patients were diagnosed with MFS according to the modified Ghent criteria^[@CR2]^. Patient data were prospectively collected from our hospital database and MFS outpatient clinic. Informed consent was obtained from all individual participants or their legal guardians included in the study. Follow-up was obtained after consent and approval of our institutional review board (Ethics committee University of Heidelberg). All research was performed in accordance with the ethical standards of the institutional committee and with the 1964 Helsinki declaration and its later amendments. All 56 surviving patients (100%) were either seen as outpatients after discharge or were contacted to obtain postoperative follow-up.

One patient was excluded from our study, who underwent aortic root replacement with a mechanical valve prosthesis due to failed VSARR, in whom a Valsalva graft had been used.

Surgical technique {#Sec3}
------------------

All patients, but one, were operated via median sternotomy with use of cardiopulmonary bypass (CPB). One patient was operated on by left parasternal thoracotomy due to severe pectus excavatum. Standard central cannulation of the ascending aorta and the right atrium were performed in 43 cases (76.7%). If indicated, venous cannulation was established by separate venae cava superior and inferior cannulation in order to perform concomitant mitral valve repair (13 patients, 23.2%) and replacement (one patient) or patent foramen ovale closure (5 patients, 8.9%). Mean core cooling was accomplished at mild hypothermia with 34 °C rectal temperature. Five patients (8.9%) underwent concomitant aortic arch procedure, therefore mean hypothermia in these selected cases was 24.3 °C. Cardiac arrest was induced by cold Bretschneider's solution (Custodiol, Dr. Franz Köhler Chemie GmbH, Bensheim, Germany).

After incision of the ascending aorta, the aneurysmal portion was excised as well as the sinuses of Valsalva. The aortic valve leaflets were then reimplanted inside the vascular Dacron graft. The coronary arteries were also reimplanted through button incisions in the vascular prosthesis. For concomitant aortic arch surgery, circulatory arrest was established by discontinuation of CPB. Selective antegrade cerebral perfusion was initiated through cannulation of the left common carotid artery and the brachiocephalic trunk. Perfusion volume was 8--12% of calculated cardiac output and perfusion pressures was held between 60--80 mmHg. Proximal graft-to-graft or graft to aortic anastomosis at various levels completed the repair.

Plication of the aortic valve had been performed in two patients, of whom one presented with bicuspid valve. Mitral valve repair was performed in 13 patients using Carpentier-Edwards Physio II (Edwards Lifesciences Corp., Irvine, USA) annuloplasty ring in all cases. Triangular resection and sliding plastic of the posterior leaflet was performed in two patients and cleft repair in another two. All other repairs (n = 9) were restricted to annuloplasty due to annular dilation. Sole patent foramen closure and chest wall repair had not been considered as relevant concomitant procedures for statistical analysis. Mitral valve intervention and surgery of the aortic arch had been considered as concomitant procedures for statistical analysis (n = 19, 34%).

Follow-up {#Sec4}
---------

Postoperative computed tomography angiograms (CTA) and magnetic resonance angiographies (MRA) were analyzed during standard follow-up visits at our MFS outpatient clinic. During these visits, echocardiography was routinely performed to evaluate postoperative aortic valve function. Patients who were seen in their referring hospital or by the referring cardiologist, were contacted to forward their recent follow-up data.

Statistical analysis {#Sec5}
--------------------

Statistical analysis was performed using IBM SPSS Statistics version 25 software (SPSS, Chicago, IL). Normally distributed continuous variables were reported as mean ± standard deviation. Categorical variables were reported as frequencies and percentages. To elaborate gender differences or differences of patients undergoing concomitant on-pump procedures (n = 19) preoperative, operative and postoperative data were analyzed by Mann-Whitney-U-test and 𝜒2 test. Freedom of aortic root intervention was estimated using the Kaplan-Meier method. Due to complete survival, no survival estimation was performed. Independent risk factors were analyzed by Cox regression analysis considering secondary interventions of the downstream aorta.

Results {#Sec6}
=======

Demographic data are given in Table [1](#Tab1){ref-type="table"}. Mean age at the time of VSARR was 32.3 ± 12.3 years with no gender differences (p = 0.191). Thirty-five patients (62.5%) were male. Mean diameter of aortic root aneurysm was 5.0 ± 0.6 cm. Thirty-three patients (58.9%) presented with aortic regurgitation (AR) before VSARR.Table 1Preoperative data.patients56male35 (62.5)age, years (range)32.34 ± 12.35 (12--60)height, cm188 ± 10weight, cm80 ± 18BMI, kg/m222.3 ± 4.6emergency2 (3.6)re-operation4 (7.1)acute aortic dissection Typ A2 (3.6)chronic aortic dissection Typ B4 (7.1)aortic regurgitation:   I19 (34)   II8 (14)   III6 (10.7)aortic root diameter, mm (range)4.95 ± 0.55 (3.9--6.5)relevant mitral regurgitation14 (25)bicuspid aortic valve2 (3.6)CAD2 (3.6)diabetes0hypertension37 (66)smoking20 (36)COPD2 (3.6)NYHA classification:   I--II43 (77)   III--IV11 (20)LV function:poor0moderate4 (7.1)good52 (93)Logistic EuroSCORE I7.96 ± 5.2creatinine, mg/dl0.8 ± 0.6bilirubin, mg/dl0.74 ± 0.18hyperlipidaemia15 (27)pulmonary hypertension2 (3.6)AAA15 (27)previous vascular intervention4 (7.1)renal impairment0Values are n (%) or mean ± SD. BMI: body mass index; CAD: coronary artery disease; COPD: chronic obstructive pulmonary disease; NYHA: New York Heart Association; LV: left ventricular; AAA: abdominal aortic aneurysm.

Intraoperative data are shown in Table [2](#Tab2){ref-type="table"}. Nineteen patients (33.9%) underwent concomitant surgical procedures other than sole chest wall repair and direct patent foramen ovale closure. Except for pectus excavatum correction, all other procedures were performed while on CPB. Only two patients (3.6%) had a bicuspid aortic valve, of whom one patient needed triangular resection and cleft closure for optimal aortic valve function.Table 2Intraoperative data.operation time, min327 ± 71CPB time, min206 ± 54cross-clamp time, min148 ± 33reperfusion time, min45 ± 19cardioplegia HTK/Bretschneider, ml2259 ± 595graft diameter, mm (median, range)28 (18--38)graft diameter/BSA, mm/m21.06cusp intervention2 (3.6)concomitant procedures26 (46.4%)MV repair/replacement13 (23.2)/1 (1.8)CABG0TVR0aortic arch surgery5 (8.9)FET1 (1.8)cardiocirculatory arrest5 (8.9)cardiocirculatory arrest time, min (range)39 (22--54)chest wall procedure2 (3.6)patent foramen ovale closure5 (8.9)blood transfusion, U1.23 ± 2.1FFP, U0.45 ± 1.1PC, U0.71 ± 0.96CS blood, U0.47 ± 0.97IABP0catecholamines:   norepinephrine5 (8.9)   dobutamine24 (43)   epinephrine2 (3.6)min. temperature, °C33.75 ± 2.8Values are n (%) or mean ± SD. CPB: cardiopulmonary bypass; BSA: body surface area; HTK: Histidine-tryptophan-ketoglutarate; MV: mitral valve; CABG: coronary artery bypass grafting; TVR: tricuspid valve repair; FET: frozen elephant trunk; FFP: fresh frozen plasma; PC: platelet concentrate; IABP: intra-aortic balloon pump.

Postoperative results are presented in Table [3](#Tab3){ref-type="table"}. One patient (1.8%) needed re-exploration for bleeding on the day of surgery. One patient developed acute kidney injury requiring dialysis. We observed 2 AV blocks, with need of pacemaker implantation for complete AV block in 1 patient. Mean ICU stay was 1.38 ± 0.98 days followed by a mean of 3.7 ± 4.3 days on our intermediate care ward.Table 3Postoperative and follow-up data.30-day/in-Hospital mortality0ICU stay, d (range)1 (0--6)respiratory insufficiency0ventilation time, h14 ± 8.6ARF4 (7.1)dialysis1 (1.8)dialysis at discharge0re-thoracotomy1 (1.8)blood transfusion, U0.75 ± 1.38FFP, U0.23 ± 0.7PC, U0.39 ± 1.48pericardial effusion5 (8.9)complete AV-block requiring pacemaker1 (1.8)hospital stay, d (range)11 (6--47)AR at dischargetrace to I°: 12; II°: 1max. creatinine, mg/dl0.76 ± 0.22max. bilirubin, mg/dl1.5 ± 1.2phrenic injury0post MI0delirium0CV accident0follow-up, d1858 ± 1161AR II-III°2 (3.6)aortic valve reintervention1 (1.8)aortic dissection type B1 (1.8)aortic arch1 (1.8)descending/thoracoabdominal aortic replacement2 (3.6)infrarenal aortic replacement2 (3.6)FET1 (1.8)death during follow-up0pacemaker implantation during follow-up0Values are n (%) or mean ± SD. ICU: intensive care unit; ARF: acute renal failure; FFP: fresh frozen plasma; PC: platelet concentrate; AR: aortic regurgitation; MI: myocardial infarction; CV: cerebrovascular; FET: frozen elephant trunk.

As expected, patients undergoing concomitant procedures while being on-pump had significantly longer cross-clamp and bypass time (p \< 0.001) and an increased need for intraoperative blood (p = 0.013) as well as platelet (p = 0.018) transfusion (Table [4](#Tab4){ref-type="table"}). Furthermore, patients undergoing concomitant procedures needed significantly more postoperative blood transfusions (p = 0.011) (Table [4](#Tab4){ref-type="table"}). Moreover, duration on ICU (p \< 0.001) was significantly longer. However, additional surgical interventions had no influence on intubation time (p = 0.99) nor hospital stay (p = 0.203). Furthermore, no significant difference between postoperative maximum bilirubin (p = 0.456) or creatinine (p = 0.343) levels nor other postoperative complications were found. Regression analysis detected no influence of concomitant surgery on secondary aortic interventions during follow-up (p = 0.255).Table 4Influence of concomitant procedures.David procedure (n = 56)with concomitant procedure (19 patients)with no concomitant procedure (37 patients)*P* valuecross-clamp time, min180 ± 28133 ± 22\<0.001bypass time, min251 ± 55182 ± 37\<0.001intraoperative blood transfusion, U2.25 ± 2.50.71 ± 1.610.013postoperative blood transfusion, U1.42 ± 1.870.41 ± 1.610.011intubation time, h17.8 ± 11.712.5 ± 5.70.99ICU stay, d2.0 ± 1.41.0 ± 0.37\<0.001hospital stay, d14 ± 9.211 ± 4.10.203log. EuroSCORE I9.2 ± 7.17.3 ± 3.80.111postoperative max. bilirubin, mg/dl1.17 ± 0.621.68 ± 1.440.456postoperative max. creatinine, mg/dl0.71 ± 0.140.79 ± 0.250.343dialysis100.159reintervention of the aortic root during follow-up100.159reintervention of the aorta during follow-up330.379Values are n (%) or mean ± SD. ICU: intensive care unit.

During follow-up echocardiography, 24 patients (43%) showed signs of trivial to mild AR, one patient (1.8%) had moderate AR and another one (1.8%) presented with severe AR. That patient underwent re-do aortic valve replacement almost 3 years (1087 days) after initial surgery.

Actuarial freedom of reintervention of the aortic root was 100% after 1 year and 97.7 ± 2.3 after 8 years (Fig. [1](#Fig1){ref-type="fig"}) and freedom of moderate and severe AR was 97.7 ± 2.3% after 1 and 95.2 ± 3.3% after 8 years (Fig. [2](#Fig2){ref-type="fig"}).Figure 1Actuarial freedom from reintervention of the aortic root.Figure 2Actuarial freedom from moderate/severe aortic regurgitation.

Reinterventions of the downstream aorta were necessary in 6 patients (10.7%). One open surgical repair for abdominal aortic aneurysm was performed 8 years after our initial surgery in another hospital, 2 patients underwent open thoraco-abdominal aortic surgery after 3 and 3.5 years respectively in our center. One patient first underwent aortic arch replacement for suture aneurysm with the elephant trunk technique one year after VSARR, then 3 weeks later received an open thoraco-abdominal vascular repair at our department. Due to Stanford type B dissection 4 years after VSARR, another patient was treated with the frozen elephant trunk technique in another hospital and one patient received endovascular aneurysm repair stent graft via bilateral transfemoral cut-down ipsilateral and iliac extension and contralateral extension from our vascular surgery department.

Regression analysis did not detect any significant predictive factors influencing early and long-term outcomes except for aortic dissection at the time of VSARR. Since 4 of the 6 patients who presented with aortic dissection at the time of operation were in need of reintervention of the downstream aorta during follow-up, a significant correlation was detected with a HR of 32.7 (CI 95% 3.6--294; p = 0.002). The entire list of analyzed parameters can be found as Supplementary Table [S1](#MOESM1){ref-type="media"}.

Discussion {#Sec7}
==========

Here, we present early and long-term results of VSARR using the reimplantation technique in patients with Marfan syndrome, over an 11-year-observation period at a single institution. Since it was first described by David *et al*.^[@CR3]^., this technique has emerged as an invaluable treatment option for aortic root aneurysm repair^[@CR9]^. Compared to the modified Bentall operation as the standard procedure for aortic root replacement, it offers various advantages such as evasion of life-long anticoagulation and reduced respective thromboembolic and endocarditis risks^[@CR10]--[@CR13]^. Hence, the therapeutic approach shifted more towards this valve-sparing technique, especially in this comparably young patient population, who in turn will benefit most from the aforementioned advantages^[@CR7],[@CR14]^.

The valve-sparing aortic root replacement technique by David and associates has been performed as the standard root replacement procedure in patients with MFS at our center since 2007, by surgeons with a pre-existing experience in performing VSARR^[@CR4],[@CR7]^. The benefit of this procedure over Yacoub's remodeling technique is still a matter of ongoing debate. However, systematic reviews favor David's method due to reduced annular dilation during follow-up^[@CR15]^. Furthermore, this approach was reported to show superior outcome results in children^[@CR16]^. This may be accounted for by the fixation of the Dacron tube to the aortic basis in the David technique, compared to an incomplete stabilization within the aortic annulus using Yacoub's method. Similarly, the valve sparing technique described by Schäfers *et al*. using an additional annular stabilization suture has also been successfully applied in Marfan's patients^[@CR17]^. Hence, outcome analysis regarding long-term durability of this surgical approach is mandatory to further underline its value in this key demographic.

With no in-hospital mortality and only one patient undergoing re-operation of the aortic root during follow-up, our excellent results are comparable to recent reports^[@CR5],[@CR8],[@CR11],[@CR14]^. In one of the longest published cohort studies, Martens *et al*. reported freedom of re-operation rates of 86% at 10 years and 80% at 20 years, in a single-center series of 104 MFS patients^[@CR8]^. Kari *et al*. found that preoperative NYHA status and aortic size, were related to adverse outcome after VSARR concerning reintervention frequency^[@CR17]^. In their study, the authors hypothesized that extensive aortic pathologies might lead to an excessive aortic downsizing during valve-sparing surgery. Thereby the risk of cusp billowing and prolapse later on, is enhanced consecutively. We did not observe the same effect, since only one patient developed AR requiring aortic valve replacement 51 month after initial surgery, despite the number of small grafts being used, especially in patients under 18 years of age. While Valsalva grafts are being utilized more frequently, almost all our patients received a classic straight tube graft, since the DAVID I procedure is the preferred technique at our center. The homogeneity of the procedure may further contribute to our excellent results.

Only 2 patients (3.6%) presented with acute aortic type A dissection and underwent emergency surgery. During follow-up, transthoracic echocardiography showed only trivial aortic valve regurgitations in both of these patients, 59 and 125 months after initial surgery, respectively. The other remaining 54 VSARR (96.4%) were elective aneurysmal aortic root replacements, which could have also contributed favorably to our outcomes. Furthermore, aortic dissection is a known risk factor with regard to reinterventions of the downstream aorta or the aortic root^[@CR18]--[@CR20]^. In our cohort operations of the aortic arch and descending aorta -- including abdominal aorta - were performed in 6 patients, of whom 4 initially presented with aortic dissections (type A or B), which is also in line with previous findings^[@CR19]--[@CR21]^. This finding was further reflected in univariate Cox regression analysis, where the presence of aortic dissection showed an increased hazard for downstream aortic reinterventions.

During follow-up, no case of valvular endocarditis, or any adverse neurological events were recorded, which is in good standing with current literature^[@CR5],[@CR8]^. Noteworthy is the observation that patients with MFS tend to develop at least one episode of postoperative blood-culture negative fever, without elevation of infectious parameters. This finding may be related to the enhanced inflammatory aspect of the aortic wall in MFS and is currently debated^[@CR22],[@CR23]^. This phenomenon has been described after aortic surgery and may also be related to other factors such as endothelialization of the prosthesis^[@CR24]^.

In general, oral anticoagulation regime with ASA 300 mg for 3 months was deemed sufficient to allow for endothelization of the Dacron graft and account for possible endovascular surface irregularities. Patients with concomitant MVR or otherwise existing indication for full anticoagulation, received oral Vitamin K Antagonist (Marcumar) to achieve target INR accordingly. Pericardial effusion was detected in 5 patients, which have been drained or conservatively treated by colchicine.

Due to the nature of the underlying disease, a substantial number of patients presented with the need for additional interventions at the time of surgery^[@CR8]^. Despite the significantly longer cross-clamp time and increased amount of blood transfusion, concomitant on-pump procedures such as MVR and arch surgery did not negatively influence postoperative outcomes. Postoperative recovery was uneventful with no postoperative occurrences of cardiac low-output or need for mechanical circulatory support. Moreover, reintervention rates were similar when compared to isolated VSARR, a finding that has not yet been addressed in other reports. Adequate cardioprotective strategies, such as use of antegrade cardioplegic solution HTK/Bretschneider, local cooling and sufficient flushing of the coronary ostia, are key elements to achieve these results.

The overall low incidence of adverse clinical events in this patient's cohort, is correlated to inherit patients' demographic, such as young age and consecutively less encountered co-morbidities. As seen in our patients' characteristics, the overall left ventricular function was preserved and most patients had a comparably high exercise capacity (NYHA I-II). Altogether determinants that have been previously identified as negative outcome predictors in other studies^[@CR14],[@CR17]^.

Aortic root interventions in MFS patients are often necessary before the beginning of the 5^th^ decade, with the median age at the time of surgery becoming progressively younger due to the expanding indication for prophylactic operations. According to current guidelines, aortic surgery is recommended in all patients with MFS presenting at a maximal aortic diameter \>50 mm^[@CR25]^. With additional risk factors, such as family history of acute aortic dissections or an expected pregnancy, MFS patients should be considered for surgery even sooner (≥45 mm)^[@CR25]^. Life expectancy of patients with MFS is now similar to that of the general population by reduction of lethal aortic complications, through the improved surgical results^[@CR26]^.

Flynn *et al*. found in their systematic review of surgical outcomes in MFS patients undergoing aortic root surgery a reduced risk of thromboembolism, late hemorrhagic complications and endocarditis compared to composite-valve graft replacement^[@CR5]^. More interestingly, they did not find a significant difference in reintervention rates between both surgical procedures, which was previously considered the limiting factor of the reimplantation technique, as reported by the meta-analysis of Benedetto *et al*.^[@CR19]^. Our data further underline the role of VSARR procedure in this patient group, even if concomitant surgical procedures are necessary. However, it is elementary to know that not all patients are suitable for VSARR. Structural defects, such as leaflet fenestration or tissue redundancy, may prevent a satisfactory VSARR. The underlying connective tissue defect in MFS may also affect the aortic cusps and therefore compromise satisfactory long-term results. The expanding indication towards prophylactic surgery may further improve long-term results, since surgical intervention is performed at an earlier stage of the disease. Preserved aortic valve integrity and reduced co-morbidities are possible advantages, due to patient's younger age.

Since only two patients presented with bicuspid aortic valves in our study cohort, a general recommendation for VSARR in these patients cannot be given. However, both patients showed no aortic regurgitation, nor structural valve disease. They are both in NYHA class I after a follow-up period of 118 and 129 months respectively. Thus, an individual case by case decision should be undertaken in these cases.

We emphasize the importance of dedicated MFS centers performing David's procedure, where competence and experience are concentrated. Our patients are monitored in our MFS clinic with regular MRA imaging of the aorta to avoid radiation. Follow-up is complete and long-term results can be collected hereby. Being able to treat MFS patients in a highly experienced, high-volume center allows complete understanding of the individual aortic pathology. It is well known that phenotypical differences as well as varying vascular involvement of MFS are present in this heterogenic patient cohort.

This study is limited by its retrospective design and thus succumbs to inherit bias. Due to the cohort size and lack of adverse events, extensive regression analysis is not possible. Moreover, we did not compare outcomes to a reference group of modified Bentall procedures, since only few patients with definitive diagnosis of MFS underwent this procedure, making a statistical analysis unfeasible.

Conclusion {#Sec8}
==========

In conclusion, we strongly recommend VSARR using David's procedure for aortic root pathologies and prophylactic surgery in patients with MFS, even if complex concomitant procedures are needed, delivering excellent early and long-term results, especially in terms of freedom from significant aortic regurgitation, thromboembolic events, reintervention and endocarditis.

Data Availability {#Sec9}
=================

All relevant data are included within the manuscript.
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